Andrew J. Fromkin
Director at Immunovant, Inc. (IMVT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $8.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 29SEC | IMVTImmunovant, Inc. | Sell | 11,483284,850 held (−4%) | $32.64 | $375K | -6.6% |
| May 29SEC | IMVTImmunovant, Inc. | Sell | 210,46874,382 held (−74%) | $33.56 | $7.1M | -9.2% |
| Dec 3SEC | IMVTImmunovant, Inc. | Sell Plan | 19,35188,750 held (−18%) | $23.14 | $448K | +31.7% |
| Dec 3SEC | IMVTImmunovant, Inc. | Sell Plan | 2,89885,852 held (−3%) | $23.95 | $69K | +27.2% |
- Sell
Director Andrew J. Fromkin sold $7.1M of IMVT at $33.56 — cuts the stake by 74%.
- Sell
Director Andrew J. Fromkin sold $448K of IMVT at $23.14 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Andrew J. Fromkin sold $69K of IMVT at $23.95 — pre-scheduled 10b5-1 plan sale.